WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 412155
CAS#: 2827-06-7 (HCl)
Description: Xyloxemine hydrochloride is a biochemical
MedKoo Cat#: 412155
Name: Xyloxemine hydrochloride
CAS#: 2827-06-7 (HCl)
Chemical Formula: C23H34ClNO2
Exact Mass: 391.2278
Molecular Weight: 391.98
Elemental Analysis: C, 70.48; H, 8.74; Cl, 9.04; N, 3.57; O, 8.16
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 2827-06-7 (HCl) 1600-19-7 (free base)
Synonym: Xyloxemine hydrochloride; Xyloxemine HCl; BS6748; BS-6748; BS 6748
IUPAC/Chemical Name: Ethanamine, 2-(2-(bis(2,6-dimethylphenyl)methoxy)ethoxy)-N,N-dimethyl-, hydrochloride
InChi Key: WDIZLVLUDKKQLC-UHFFFAOYSA-N
InChi Code: InChI=1S/C23H33NO2.ClH/c1-17-9-7-10-18(2)21(17)23(22-19(3)11-8-12-20(22)4)26-16-15-25-14-13-24(5)6;/h7-12,23H,13-16H2,1-6H3;1H
SMILES Code: CC1=C(C(C2=C(C)C=CC=C2C)OCCOCCN(C)C)C(C)=CC=C1.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 391.98 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Hespe W, Prins H, Kafoe WF, Nauta WT. The distribution and metabolic fate of xyloxemine hydrochloride in mice and rats. Arch Int Pharmacodyn Ther. 1967 Dec;170(2):397-408. PMID: 6076587.
2: van Eeken CJ, Mulder D. The influence of xyloxemine hydrochloride, 2-[2-(DI-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride, on reproduction in laboratory animals. Arch Int Pharmacodyn Ther. 1967 May;167(1):135-41. PMID: 6035090.
3: Doorenbos HJ, Rekker RF, Nauta WT. Investigation of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748). Pharm Weekbl. 1966 Jul 1;101(26):565-9. PMID: 5916606.
4: Tersteege HM, Funcke AB, Louwerse WJ, Nauta WT. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent. Arch Int Pharmacodyn Ther. 1966 Jun;161(2):314-33. PMID: 5926874.
